2022 annual financial data
Bolt Biotherapeutics 2022 Operating margin
Bolt Biotherapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1,576.56%.
Operating income was -90,321,000 USD and net income was -88,098,000 USD.
Operating cash flow was -76,504,000 USD.
Get free Bolt Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,729,000 USD
- Operating income
- -90,321,000 USD
- Net income
- -88,098,000 USD
- Operating cash flow
- -76,504,000 USD